Free Trial
LON:IDP

InnovaDerma (IDP) Share Price, News & Analysis

InnovaDerma logo
GBX 29 0.00 (0.00%)
(As of 05/30/2022)

About InnovaDerma Stock (LON:IDP)

Key Stats

Today's Range
28.66
29
50-Day Range
29
29
52-Week Range
25
45.50
Volume
5,000 shs
Average Volume
106,039 shs
Market Capitalization
£8.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

InnovaDerma PLC, through its subsidiaries, engages in the research, manufacture, and marketing of clinically proven products in life sciences, beauty, and personal care products in the United Kingdom, the United States, Australasia, and the Asia Pacific region. The company offers a range of men's skincare products, including hand and body washes, hand creams, face washes, and face moisturizers under the Charles + Lee brand name; and hair removal wax and jelly, and shave and shower sorbet under the Nuthing brand. It also provides tanning mousses, tanning gels, tanning oils, primers, moisturizers, and applicators under the Skinny Tan brand name; Prolong, a Class II medical device for the treatment of premature ejaculation; haircare products comprising shampoos, conditioners, and spray treatment for men and women to aid hair regrowth and hair thickening under the Roots brand name; and hair growth products under the GrowLase brand. The company sells its products through online and DTC channels. InnovaDerma PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.

Receive IDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovaDerma and its competitors with MarketBeat's FREE daily newsletter.

IDP Stock News Headlines

IDP Education: IDP to acquire Intake Education
I've got news for you…
Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week
See More Headlines

IDP Stock Analysis - Frequently Asked Questions

InnovaDerma's stock was trading at GBX 29 on January 1st, 2024. Since then, IDP shares have increased by 0.0% and is now trading at GBX 29.
View the best growth stocks for 2024 here
.

InnovaDerma PLC (LON:IDP) issued its earnings results on Wednesday, September, 30th. The company reported ($2.00) EPS for the quarter, missing analysts' consensus estimates of $9.50 by $11.50.

Shares of IDP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that InnovaDerma investors own include Sol-Gel Technologies (SLGL), Synovus Financial (SNV), Venator Materials (VNTR), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), BJ's Restaurants (BJRI) and Christopher & Banks (CBK).

Company Calendar

Last Earnings
9/30/2020
Today
11/24/2024

Industry, Sector and Symbol

Industry
Specialty Retail
Sub-Industry
Pharmaceutical Products
CIK
N/A
Fax
N/A
Employees
8,720
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£9.82 million
Cash Flow
GBX 4.90 per share
Book Value
GBX 7.90 per share

Miscellaneous

Free Float
N/A
Market Cap
£8.14 million
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (LON:IDP) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners